Olmetrack CT 12.5 Tablet
By Olmetrack CT
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(20mg) + Chlorthalidone(12.5mg)

Manufacturer - USV Ltd
Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai - 400 088. , India.

Expires on or after
October, 2026

liver
When it comes to using Olmetrack CT 12.5 Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require adjustments in the dosage of this tablet. It is highly advised to consult your doctor before using this medication if you have any liver concerns. Remember that Olmetrack CT 12.5 Tablet is not recommended for individuals with severe liver disease. Prioritize your liver health and seek professional medical advice to ensure safe usage of this medication.

kidney
Olmetrack CT 12.5 Tablet requires caution in severe kidney disease. Adjustments in dosage may be necessary. It is not recommended for these patients; consult your doctor.

alcohol
When taking Olmetrack CT 12.5 Tablet, be cautious as it may lead to increased drowsiness when consumed with alcohol.

driving
When taking Olmetrack CT 12.5 Tablet, be cautious as it may reduce alertness, impact vision, or cause drowsiness and dizziness. It is advised not to drive if experiencing these effects.

pregnancy
During pregnancy, avoid using Olmetrack CT 12.5 Tablet as it can harm the developing baby. However, in life-threatening situations, a doctor might prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Caution is advised when breastfeeding while taking Olmetrack CT 12.5 Tablet, as it may be unsafe for the baby due to potential transfer of the drug through breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹140.2
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024